Ciputra Development Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Ciputra Development Tbk trades at Rp560 (market cap 10.29T, 11.27M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Ciputra Development Tbk and Tempo Scan Pacific Tbk. are close in size by market cap, and Ciputra Development Tbk is more actively traded (11.27M versus 613K). Which is the better fit depends on your goals.
| CTRA | TSPC | |
|---|---|---|
Market Cap | 10.29T | 11.18T |
Volume | 11.27M | 613K |
Lot | 112.75K | 6.13K |
Turnover | 6.32B | 1.54B |
Average Price | 560.45 | 2,511.52 |
Value | 6.32B | 1.54B |
Indicative Equilibrium Price | 560 | 2,520 |
Indicative Equilibrium Volume | 3.05K | 17 |
Trailing returns across standard periods
Latest headlines on both assets
PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.
Read more on CTRA →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →